Safety profile of a nicotine lozenge compared with thatof nicotine gum in adult smokers with underlying medical conditions: A 12-week, randomized, open-label study

Clinical Therapeutics

Volumn 27, Issue 10, 2005, Pages 1571-1587

  Marsh, Howard S ^a   Dresler, Carolyn M ^a   Choi, Jae H ^a   Targett, Darren A ^b   Gamble, Michael L ^a   Strahs, Kenneth R ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Gum; Lozenge; Nicotine replacement therapy; Randomized study; Safety

Indexed keywords

NICOTINE; NICOTINE GUM;

ABDOMINAL PAIN; ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; BODY WEIGHT; BRONCHITIS; CARDIOTOXICITY; CLINICAL TRIAL; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG EXPOSURE; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DYSGEUSIA; DYSPEPSIA; FEMALE; GINGIVA DISEASE; HEADACHE; HEALTH STATUS; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HICCUP; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; LARYNX DISORDER; LOZENGE; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MULTICENTER STUDY; NAUSEA; PAIN; PHARYNX DISEASE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; THORAX PAIN; TIME SERIES ANALYSIS; TOBACCO DEPENDENCE; TOOTH PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ALGORITHMS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHEWING GUM; FEMALE; GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NICOTINE; POLYMETHACRYLIC ACIDS; POLYVINYLS; RESPIRATORY TRACT DISEASES; SMOKING CESSATION; TABLETS; TIME FACTORS; TOBACCO USE DISORDER; UNITED STATES;

EID: 28444460196     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.10.008     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention (CDC) Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999 MMWR Morb Mortal Wkly Rep 51 2002 300 303
2. Fiore M.C., Bailey W.C., and Cohen S.J. Treating Tobacco Use and Dependence. Clinical Practice Guideline June 2000 US Dept of Health and Human Services, Public Health Service Rockville, Md
3. Silagy C., Lancaster T., and Stead L. Nicotine replacement therapy for smoking cessation Cochrane Database Syst Rev 3 2004 CD000146
4. Commit nicotine polacrilex lozenge [package insert] 2005 GlaxoSmithKline Consumer Healthcare Pittsburgh, Pa
5. Nicorette nicotine polacrilex gum [package insert] 2005 GlaxoSmithKline Consumer Healthcare Pittsburgh, Pa
6. Dacosta A., Guy J.M., and Tardy B. Myocardial infarction and nicotine patch: A contributing or causative factor? Eur Heart J 14 1993 1709 1711
7. Pierce J.R. Jr Stroke following application of a nicotine patch Ann Pharmacother 28 1994 402
8. Warner J.G. Jr, and Little W.C. Myocardial infarction in a patient who smoked while wearing a nicotine patch Ann Intern Med 120 1994 695
9. Ottervanger J.P., Festen J.M., de Vries A.G., and Stricker B.H. Acute myocardial infarction while using the nicotine patch Chest 107 1995 1765 1766
10. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease Nicotine replacement therapy for patients with coronary artery disease Arch Intern Med 154 1994 989 995
11. Joseph A.M., Norman S.M., and Ferry L.H. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease N Engl J Med 335 1996 1792 1798
12. Mahmarian J.J., Moye L.A., and Nasser G.A. Nicotine patch therapy in smoking cessation reduces the extent of exerciseinduced myocardial ischemia J Am Coll Cardiol 30 1997 125 130
13. Kimmel S.E., Berlin J.A., and Miles C. Risk of acute first myocardial infarction and use of nicotine patches in a general population J Am Coll Cardiol 37 2001 1297 1302
14. Benowitz N.L. The role of nicotine in smoking-related cardiovascular disease Prev Med 26 1997 412 417
15. Choi J.H., Dresler C.M., Norton M.R., and Strahs K.R. Pharmacokinetics of a nicotine polacrilex lozenge Nicotine Tob Res 5 2003 635 644
16. Fagerstrom K. Time to first cigarette: The best single indicator of tobacco dependence? Monaldi Arch Chest Dis 59 2003 91 94
17. Fattinger K., Verotta D., and Benowitz N.L. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans J Pharmacol Exp Ther 281 1997 1238 1246
18. Shiffman S., Dresler C.M., and Hajek P. Efficacy of a nicotine lozenge for smoking cessation Arch Intern Med 162 2002 1267 1276
19. Prague, Czech Republic. Abstract Durcan M.J., Ciesla R., and Martin A. Assessing the safety profile of the nicotine lozenge in a "real world, ac tual use" setting Presented at: 11th Annual Meeting of the Society for Research on Nicotine and Tobacco March 20-23 2005
20. Tonnesen P., Fryd V., and Hansen M. Two and four mg nicotine chewing gum and group counselling in smok ing cessation: An open, randomized, controlled trial with a 22 month follow-up Addict Behav 13 1988 17 27
21. Murray R.P., Bailey W.C., Daniels K. Lung Health Study Research Group Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study Chest 109 1996 438 445
22. Fagerstrom K.O., Tejding R., Westin A., and Lunell E. Aiding reduction of smoking with nicotine replacement medications: Hope for the recalcitrant smoker? Tob Control 6 1997 311 316
23. Bolliger C.T., Zellweger J.P., and Danielsson T. Smoking reduction with oral nicotine inhalers: Double blind, randomised clinical trial of efficacy and safety BMJ 321 2000 329 333
24. Stahl M.M., Wohlfart B., and Pahlm O. Tolerability of concurrent use of nicotine gum and smoking in healthy volunteers Nicotine Tob Res 3 2001 157 165
25. Carpenter M.J., Hughes J.R., and Keely J.P. Effect of smoking reduction on later cessation: A pilot experimental study Nicotine Tob Res 5 2003 155 162
26. Wennike P., Danielsson T., and Landfeldt B. Smoking reduction promotes smoking cessation: Results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-yearfollow-up Addiction 98 2003 1395 1402
27. Godtfredsen N.S., Osler M., and Vestbo J. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: A pooled cohort study J Epidemiol Community Health 57 2003 412 416
28. Hurt R.D., Croghan G.A., and Wolter T.D. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler Nicotine Tob Res 3 2000 327 336
29. Bolliger C.T., Zellweger J.P., and Danielsson T. Influence of long-term smoking reduction on health risk markers and quality of life Nicotine Tob Res 4 2002 433 439